Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Manoj Amrutkar

Scientist

Oslo University Hospital

Norway

Research Interests

Explore related searches

Professors in Norway Professors in Cell Biology Cell Biology professors in Norway

Articles (8)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Collaborators (6)

Bengt Hallberg

Prof

University of Gothenburg

SWEDEN

View details

Margit Mahlapuu

Professor in Molecular Genetics

SWEDEN

View details

Caroline Verbeke

Prof. Dr

University of Oslo

NORWAY

View details

Knut Jørgen Labori

Professor

Oslo University Hospital

NORWAY

View details

Andrew Hoy

Associate Professor

University of Sydney

AUSTRALIA

View details

Surinder K. Batra

Professor & Chair

University of Nebraska Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Manoj Amrutkar

Research Interests

Explore related searches

Articles (8)

Therapeutic Potential of STE20-Type Kinase STK25 Inhibition for the Prevention and Treatment of Metabolically Induced Hepatocellular Carcinoma.

Knowledge Discovery in Databases of Proteomics by Systems Modeling in Translational Research on Pancreatic Cancer

Proteomic Characterization of Primary Human Pancreatic Cancer Cell Lines Following Long-Term Exposure to Gemcitabine

Proteomics profiling of research models for studying pancreatic ductal adenocarcinoma.

Global metabolomic profiling of tumor tissue and paired serum samples to identify biomarkers for response to neoadjuvant FOLFIRINOX treatment of human pancreatic cancer

Genetic Ablation of STE20-Type Kinase MST4 Does Not Alleviate Diet-Induced MASLD Susceptibility in Mice

Unravelling the complexities of resistance mechanism in pancreatic cancer: Insights from in vitro and ex-vivo model systems.

Neoadjuvant chemotherapy is associated with an altered metabolic profile and increased cancer stemness in patients with pancreatic ductal adenocarcinoma

Collaborators (6)

Bengt Hallberg

Margit Mahlapuu

Caroline Verbeke

Knut Jørgen Labori

Andrew Hoy

Surinder K. Batra

Make your next move.